Average marginal decline in life expectancy for each additional chronic condition is 1.8 years.
Reduced risk for male and female childhood cancer survivors who adhere to WCRF/AICR guidelines.
Pain intensity linked to degree of inflammation, ulceration, perineural invasion, depth of invasion.
Registry data show increase in incidence rates of HPV-related oropharyngeal and anal cancers.
Findings only seen in more anxiously attached patients in year following diagnosis.
Retrospective cohort study in Taiwan shows significantly increased risk of cancer.
Epigenetic assay has a high negative predictive value for prostate cancer.
People with chronic lymphocytic leukemia and 17p deletion can now get the therapy.
A newly developed blood test could help doctors rule out cancer in patients.
Oncologist and gynecologist should collaborate to provide appropriate treatment.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|